United States · FDA National Drug Code directory
Bisoprolol Fumarate and Hydrochlorothiazide
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1761_9d6e36f0-a9e4-4b66-997a-fd5f8e4e1cf7
- Product NDC
- 70771-1761
- Form
- TABLET, FILM COATED
- Composition / generic term
- bisoprolol fumarate and hydrochlorothiazide
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20230301
- Source listing expiry
- 20261231
Source-listed ingredients
- BISOPROLOL FUMARATE — 5 mg/1
- HYDROCHLOROTHIAZIDE — 6.25 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (70771-1761-1) · 70771-1761-1
- 30 TABLET, FILM COATED in 1 BOTTLE (70771-1761-3) · 70771-1761-3
- 500 TABLET, FILM COATED in 1 BOTTLE (70771-1761-5) · 70771-1761-5
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →